Literature DB >> 12930324

Two German CINCA (NOMID) patients with different clinical severity and response to anti-inflammatory treatment.

Angela Rösen-Wolff1, Jürgen Quietzsch, Heinz Schröder, Romy Lehmann, Manfred Gahr, Joachim Roesler.   

Abstract

Chronic infantile neurologic, cutaneous, articular (CINCA) syndrome is characterized by fever, chronic meningitis, uveitis, sensorineural hearing loss, urticarial skin rash, and a deforming arthritis. In the CIAS1 gene of many but not all CINCA patients, disease-associated mutations have been found recently. We here describe two such patients from Germany. One of them, a 3-yr-old boy, has a 1709A-->G, Y570C, mutation, which has previously been described to cause CINCA syndrome. His clinical course is very severe and no satisfying response has been achieved even with high doses of local and systemic steroids. The other patient has a somewhat milder clinical course and considerable improvement could be accomplished with moderate and low doses of steroids. In her CIAS1 gene we have found a 1043C-->T, T348M, mutation, which has only been detected in Muckle-Wells syndrome before. Our results suggest that the severity of symptoms in CINCA patients may be influenced by the underlying mutation in the CIAS1 gene. Furthermore, our observations support the view that CINCA syndrome and Muckle-Wells syndrome are essentially the same disease with different degrees of severity.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12930324     DOI: 10.1034/j.1600-0609.2003.00109.x

Source DB:  PubMed          Journal:  Eur J Haematol        ISSN: 0902-4441            Impact factor:   2.997


  6 in total

1.  High incidence of NLRP3 somatic mosaicism in patients with chronic infantile neurologic, cutaneous, articular syndrome: results of an International Multicenter Collaborative Study.

Authors:  Naoko Tanaka; Kazushi Izawa; Megumu K Saito; Mio Sakuma; Koichi Oshima; Osamu Ohara; Ryuta Nishikomori; Takeshi Morimoto; Naotomo Kambe; Raphaela Goldbach-Mansky; Ivona Aksentijevich; Geneviève de Saint Basile; Bénédicte Neven; Mariëlle van Gijn; Joost Frenkel; Juan I Aróstegui; Jordi Yagüe; Rosa Merino; Mercedes Ibañez; Alessandra Pontillo; Hidetoshi Takada; Tomoyuki Imagawa; Tomoki Kawai; Takahiro Yasumi; Tatsutoshi Nakahata; Toshio Heike
Journal:  Arthritis Rheum       Date:  2011-11

2.  The anesthetic management of children with neonatal-onset multi-system inflammatory disease.

Authors:  Christine F Lauro; Raphaela Goldbach-Mansky; Margaret Schmidt; Zenaide M N Quezado
Journal:  Anesth Analg       Date:  2007-08       Impact factor: 5.108

3.  Canakinumab (ACZ885, a fully human IgG1 anti-IL-1β mAb) induces sustained remission in pediatric patients with cryopyrin-associated periodic syndrome (CAPS).

Authors:  Jasmin B Kuemmerle-Deschner; Eduardo Ramos; Norbert Blank; Joachim Roesler; Sandra D Felix; Thomas Jung; Kirstin Stricker; Abhijit Chakraborty; Stacey Tannenbaum; Andrew M Wright; Christiane Rordorf
Journal:  Arthritis Res Ther       Date:  2011-02-28       Impact factor: 5.156

Review 4.  The PANoptosome: A Deadly Protein Complex Driving Pyroptosis, Apoptosis, and Necroptosis (PANoptosis).

Authors:  Parimal Samir; R K Subbarao Malireddi; Thirumala-Devi Kanneganti
Journal:  Front Cell Infect Microbiol       Date:  2020-06-03       Impact factor: 5.293

5.  Computational Modeling of NLRP3 Identifies Enhanced ATP Binding and Multimerization in Cryopyrin-Associated Periodic Syndromes.

Authors:  Jenny Mae Samson; Dinoop Ravindran Menon; Prasanna K Vaddi; Nazanin Kalani Williams; Joanne Domenico; Zili Zhai; Donald S Backos; Mayumi Fujita
Journal:  Front Immunol       Date:  2020-11-19       Impact factor: 7.561

6.  Ocular manifestations in Chinese adult patients with NLRP3-associated autoinflammatory disease.

Authors:  Tianli Meng; Di Wu; Yi Luo; Na Wu; Mengzhu Zhao; Min Shen; Weihong Yu
Journal:  Sci Rep       Date:  2021-06-07       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.